Image Discovering Early Lung Cancer Project (IDEALCAP)

July 31, 2013 updated by: Cathay General Hosp. IRB, Cathay General Hospital

Low-Dose Computed Tomography for Lung Cancer Screening in High Risk Asymptomatic Patients: the Taiwan Study

Lung cancer is the leading cause of cancer related death in Taiwan and world wide. The application of low dose helical computed tomography (CT) has been the milestone of lung cancer screening. Recently, The National Lung Screening Trial (NLST) shows screening with low-dose CT could reduce mortality from lung cancer. We conducted this clinical trial to determine the efficacy of low dose CT in early lung cancer screening in Taiwan.

Study Overview

Status

Unknown

Conditions

Detailed Description

This is a single center, single arm, non-randomized prospective study. We plan to enroll persons between 50 and 74 years in age, who had cigarette smoking of at least 30 pack-years, and, if former smokers, had quit within the previous 15 years. Persons who had previously received a diagnosis of lung cancer, had undergone chest CT within 18 months before enrollment, had hemoptysis, or had an unexplained weight loss of more than 6.8 kg in the preceding year were excluded.

All the participants should complete a questionnaire that covers many topics, including demographic characteristics and smoking behavior. We also plan to collect additional data for planned analyses of cost-effectiveness, and smoking cessation. Lung-cancer got by biopsy and other biospecimens are available to researchers through a peer-review process All screening examinations are planed to perform in accordance with a standard protocol, developed by medical physicists associated with the trial, that specified acceptable characteristics of the machine and acquisition variables. All low-dose CT scans are acquired with the use of multidetector scanners with a minimum of 16 channels.

IDEALCAP radiologists are certified by appropriate agencies or boards and has completed training in image acquisition; radiologists also has completed training in image quality and standardized image interpretation. Images are interpreted first in isolation and then in comparison with available historical images and images from prior IDEALCAP screening examinations.

IDEALCAP primary analysis is the detection rate of lung cancer. Secondary analysis include the detection rate of lung nodule, 5-year survival rate of persons with lung cancer who receive standard surgical treatment, 5-year survival rate of persons with lung cancer who receive alternative treatment other than standard surgical treatment (ex. Radiotherapy, chemotherapy or target therapy), the correlation of CT images and cigarette smoking history, the correlation of CT images and pulmonary function.

Key Word: low dose computed-tomography (LDCT), lung cancer screening

Study Type

Interventional

Enrollment (Anticipated)

600

Phase

  • Phase 2

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Lotung, Taiwan
        • Recruiting
        • Lotung Pohai General hospital
        • Principal Investigator:
          • Chung-Huang Hubert Chan, Doctor

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

48 years to 72 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age 50-74 years
  • 30 or more pack-years of cigarette smoking history
  • Former smokers: quit smoking within the previous 15 years
  • Ability to tolerate CT procedure
  • Signed informed consent

Exclusion Criteria:

  • Severe uncontrolled heart, vascular, respiratory or endocrine pathology.
  • Life-expectancy less than 1 year
  • History of lung cancer
  • Acute respiratory disease
  • Hemoptysis.
  • Weight loss more than 6.8 kg in the 12 months prior to eligibility assessment
  • Participation in other cancer clinical trial
  • Chest CT examination in the 12 months prior to eligibility assessment.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Low-dose computed tomography (LDCT)
Patients will have one baseline LDCT scan.
Low-dose computed tomography scan
Other Names:
  • LDCT scan

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Lung cancer detection rate
Time Frame: 2 years
Assess number of lung cancer diagnoses after radiological and morphological verification of positive lung nodules.
2 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Lung cancer mortality
Time Frame: 5 years
Assess lung cancer mortality in the screened group within next 5 years.
5 years
All-cause mortality
Time Frame: 5 years
Assess all-cause mortality mortality within next 5 years.
5 years
Nodule detection rate
Time Frame: 3 months
Estimate nodule detection rate, types (solid, part-solid, or ground glass opacity) and sizes of lung nodules found.
3 months
Smoking cessation rate
Time Frame: one year
Assess smoking cessation rate in the screened group within next one year.
one year

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Coronary artery calcification
Time Frame: 3 months
Estimate coronary artery calcification score (Agatston Score)in the screened group.
3 months
Incidence rate of cardiovascular accident
Time Frame: 5 years
Incidence rate of cardiovascular accident stratified by coronary artery calcification score in the screened group within next 5 years.
5 years
Diagnosis accuracy of COPD diagnosis by low-dose computed tomography(CT)
Time Frame: 2 years
Assess diagnosis accuracy of COPD diagnosis by low-dose computed tomography(CT) (CT emphysema, CT air trapping) according to the reference standard of pulmonary function tests.
2 years
Lung nodules management
Time Frame: 12 months
Assess algorithms for lung nodules management in a regional general hospital in Taiwan.
12 months
Frequency of diagnostic procedures
Time Frame: 12 months
Estimate the frequency of diagnostic procedures, types of invasive and non-invasive procedures performed in a regional hospital in Taiwan.
12 months
Complication of diagnostic procedures
Time Frame: 12 months
Assess the complication rate after diagnostic procedures performed after screening in a regional hospital in Taiwan. Procedures include baseline LDCT.
12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Chung-Huang Hubert Chan, Doctor, CH Chan

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

February 1, 2013

Primary Completion (Anticipated)

January 1, 2018

Study Registration Dates

First Submitted

July 28, 2013

First Submitted That Met QC Criteria

July 31, 2013

First Posted (Estimate)

August 2, 2013

Study Record Updates

Last Update Posted (Estimate)

August 2, 2013

Last Update Submitted That Met QC Criteria

July 31, 2013

Last Verified

July 1, 2013

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Lung Cancer

Clinical Trials on Low-dose computed tomography (LDCT)

3
Subscribe